BioCentury
ARTICLE | Financial News

Biotech stocks rise after positive AD data

July 6, 2018 11:25 PM UTC

Biotech indexes gained Friday after Biogen Inc. (NASDAQ:BIIB) and Eisai Co. Ltd. (Tokyo:4523) reported 18-month data for BAN2401 to treat Alzheimer's disease.

Biogen gained $58.67 (20%) to $357.48, adding about $12.3 billion in market cap, after the partners announced late Thursday that one dose group receiving BAN2401 met two secondary endpoints in the Phase II Study 201. Eisai added ¥1,500 (19%) to ¥9,206 (see "BAN2401 Slows AD Progression at 18 Months"). ...